New suicide prevention program aims to save Women's lives in tajikistan
NCT ID NCT07453758
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a suicide prevention program called SUSTAIN, led by nurses and peers, for women at moderate to high suicide risk in Tajikistan. 96 women will be randomly assigned to either the SUSTAIN program or enhanced usual care, and followed for 9 months. The program includes individual, group, and family sessions over 8-12 weeks, aiming to reduce suicidal thoughts and attempts.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SUSTAIN intervention (behavioral therapy sessions)
What this could lead to
If successful, this could provide an effective, scalable suicide prevention model for women in low-resource settings.
What could go wrong
This is a small pilot study with only 96 participants, so results may not apply broadly. The intervention may not reduce suicide risk more than usual care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SUICIDE IDEATION are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
PRISMA research center
Dushanbe, Tajikistan